Actively Recruiting
Proof-of-Concept Study of the SNOEZELEN Device on Anxiety Symptoms in Patients Hospitalized for Chemotherapy in a Pediatric Oncology Department
Led by Centre Oscar Lambret · Updated on 2026-03-18
20
Participants Needed
1
Research Sites
8 weeks
Total Duration
On this page
Sponsors
C
Centre Oscar Lambret
Lead Sponsor
P
PETRARQUE
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to evaluate whether the Snoezelen multisensory relaxation approach can reduce anxiety symptoms in children and adolescents aged 8 to 17 years hospitalized for chemotherapy in a pediatric oncology unit. Researchers will compare patients' symptoms during a chemotherapy cycle with Snoezelen sessions to a previous cycle without Snoezelen, in order to assess changes in psychological and physical well-being. Participants will: * Be enrolled between their first (without Snoezelen) and second (with Snoezelen) chemotherapy cycles * Complete self-report questionnaires on anxiety, depression, quality of life, and nausea * Receive 45-minute Snoezelen sessions every two days during their second hospitalization * Participate in a semi-structured interview after the final session * Provide data on medications (anxiolytics, antiemetics) and vomiting frequency during both hospitalizations
CONDITIONS
Official Title
Proof-of-Concept Study of the SNOEZELEN Device on Anxiety Symptoms in Patients Hospitalized for Chemotherapy in a Pediatric Oncology Department
Who Can Participate
Eligibility Criteria
You may qualify if you...
- New patient
- Treated in the Paediatrics/AJA department of the Oscar Lambret Centre for cancer (all types of cancer)
- Hospitalisation for several days
- Highly emetogenic chemotherapy treatment as carried out in the Paediatrics/AJA department
- Age at diagnosis: 8 years or older and younger than 18 years
- French language speaking
- Information provided and consent signed by the patient and those with parental authority
- Valid social security coverage
You will not qualify if you...
- Contraindication to Snoezelen, including claustrophobia
- Presence of psychiatric, addictive, or cognitive disorders preventing compliance with study requirements
- Health condition not allowing participation (severe fatigue, symptoms refractory to treatment)
- Pregnant or breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Oscar Lambret
Lille, France, 59000
Actively Recruiting
Research Team
F
Fanny BEN OUNE
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here